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Edited by Michael R. BubbAbstract Oligomerization of G protein-coupled receptors
(GPCRs) is known to play important roles in regulating receptor
pharmacology and function. Whereas many bivalent GPCR
interactions have been described, the stoichiometry and localiza-
tion of GPCR oligomers are largely unknown. We have used
bimolecular ﬂuorescence complementation (BiFC) to study
adenosine A2A receptor (A2AR) oligomerization. The data sug-
gest speciﬁcity of the A2AR/A2AR interaction monitored by BiFC
and proper sub-cellular localization of tagged receptors. More-
over, using a novel approach combining ﬂuorescence resonance
energy transfer and BiFC, we found that at least three A2A
receptors assemble into higher-order oligomers at the plasma
membrane in Cath.A diﬀerentiated neuronal cells.
Structured summary:
MINT-6797156, MINT-6797142:
A2AR (uniprotkb:P29274) physically interacts (MI:0218) with
A2AR (uniprotkb:P29274) by bimolecular ﬂuorescence comple-
mentation (MI:0809)
MINT-6797129:
A2AR (uniprotkb:P29274) physically interacts (MI:0218) with
A2AR (uniprotkb:P29274) by ﬂuorescent resonance energy
transfer (MI:0055)
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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With approximately 1000 members, the GPCR superfamily
is the largest class of membrane receptors in mammals, serving
as targets for many therapeutic drugs. A growing number of
GPCRs are known to exist as dimers. Although several
GPCRs may be able to signal to their eﬀectors as monomers
[1,2], dimerization often confers unique functional properties
and/or pharmacological proﬁles to receptors, and may hence*Corresponding author. Fax: +1 765 494 1414.
E-mail address: wattsv@purdue.edu (V.J. Watts).
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doi:10.1016/j.febslet.2008.09.062represent an important regulatory mechanism for GPCR func-
tion [3–6].
The adenosine A2A receptors are highly expressed on striatal
spiny neurons [7] where they positively regulate adenylyl cy-
clase (AC) activity through coupling to Gas/olf. A2AR homodi-
mer [8–10], as well as heterodimer complexes, notably with
dopamine D2 receptors (D2R) [3,11–13], have been reported.
A2AR (as well as other GPCRs), may further associate as high-
er-order oligomers in signaling complexes. Consistent with this
hypothesis is the observation that A2AR/D2R heterodimers co-
localize with A2AR/A2AR homodimers [14]. To examine the
possibility of higher-order complex formation, we have used
a combination of bimolecular ﬂuorescence complementation
(BiFC) [15] and ﬂuorescence (Forster) resonance energy trans-
fer (FRET) techniques in Cath.A diﬀerentiated (CAD) neuro-
nal cells. The results indicate that A2A receptors associate in
higher-order oligomers at the plasma membrane.2. Materials and methods
2.1. Materials
A2AR, M4R and D1R cDNAs were obtained from the Missouri S&T
cDNA Resource Center. Growth media and reagents (unless otherwise
stated) were purchased from Sigma–Aldrich (St. Louis, MO).2.2. Expression vectors
Human A2AR and D1R coding sequences were cloned in pBiFC vec-
tors [16] to generate C-terminal fusions with fragments from Venus or
Cerulean ﬂuorescent proteins, as described [14]. N-terminal fragments
from Venus or Cerulean (VN or CN) encompass residues 1–172
whereas C-terminal fragments (VC or CC) consist of residues 155–
238. To generate VN and VC fusions to the human muscarinic M4
receptor, M4R coding sequence was ampliﬁed by polymerase chain
reaction using 5 0 cgg aat tct tAT GGC CAA CTT CAC ACC TGT
C 3 0 and 5 0 cgc tcg agc CCT GGC AGT GCC GAT GTT C 3 0oligo-
nucleotides, and inserted between the EcoRI and XhoI sites from
pBiFC-VN or pBiFC-VC. The M4R-Venus construct was obtained
by swapping VN with the Venus coding sequence. The constructs were
veriﬁed by DNA sequencing.2.3. Cell culture and transient gene expression
CAD cells were maintained as described previously [17]. Cells were
grown to 70% conﬂuency in 12-well plates for whole cell ﬂuorescence
measurements or in four-well Lab-Tek chambered coverslips (Nunc,
Rochester, NY) for microscopy. Cells were transfected using 2 ll
(12-well plates) or 1 ll (coverslips) Lipofectamine 2000 (Invitrogen,
Carlsbad, CA), according to the manufacturers recommendations.
DNA amounts per well in 12-well plates were 300 ng (A2AR, D1R,blished by Elsevier B.V. All rights reserved.
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were 100 ng (A2AR), 200 ng (M4R), or 20 ng (mCherry-Mem, YFP-
Endo, YFP-Golgi, and YFP-ER).
2.4. Fluorescence measurement in cell suspensions
CAD cells were suspended in PBS and transferred into 96-well plates
(Nunc; 40 lg protein/well). Protein concentration was determined
using the BCA method (Pierce, Rockford, IL). Cerulean and Venus
ﬂuorescence were measured with a multi-well plate reader (FUSION
Packard, Waltham, MA) using 430/25 nm and 500/20 nm excitation,
as well as 470/30 nm and 535/30 nm emission ﬁlters, respectively.
Mock-transfected cells were used for background subtraction. BiFC
signals were normalized with signals from co-transfected Cerulean.
FRET signals (F) were measured using the sensitized acceptor method.
For each sample, Cerulean (C) and Venus (V) ﬂuorescence was mea-
sured as above. In addition, FRET signals were collected using 430/
25 nm excitation and 535/30 nm emission ﬁlters. Acceptor bleed-
through (a = F/V) and donor cross-talk (d = F/C) coeﬃcients were
determined with cells expressing either Venus or Cerulean fusion pro-
teins. Corrected FRET signals (cFRET) were calculated according to
the equation
cFRET ¼ F aV dC
and normalized with donor (C) and acceptor (V) ﬂuorescence intensi-
ties as
N FRET ¼ cFRET=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðC VÞ
p
2.5. Microscopy
Twenty four hours post-transfection, the growth medium was re-
placed with PBS and cells were imaged using a charge-coupled device
camera mounted on a TE2000-U inverted ﬂuorescence microscope (Ni-
kon Instruments Inc., Melville, NY) equipped with a 100 W mercury
lamp and band-pass ﬁlters (Chroma, Rockingham, VT) for Venus
(500/20 nm excitation, 535/30 nm emission), Cerulean (430/25 nm exci-
tation, 470/30 nm emission) or mCherry (572/23 nm excitation). Fluo-Fig. 1. A2AR oligomerization detected with BiFC. (A) Signals from Venus co
VC or M4R-VC, as well as signals from the co-transfected membrane mar
Fluorescence intensity in cells expressing A2AR-VN and A2AR-VC, D1R-
normalized with co-transfected Cerulean. Data are means ± S.E.M. from t
indicate signiﬁcant diﬀerences (P < 0.001; One-way ANOVA followed by B
expressed in HEK293 or CAD cells. Fluorescence complementation, as w
ﬂuorescence microscopy. Scale bars: 5 lm.rescent images were acquired using the MetaMorph software
(Molecular Devices, Sunnyvale, CA) and images were analyzed using
ImageJ (http://rsbweb.nih.gov/ij/) as previously described [14].2.6. FLIM analysis
Fluorescence lifetime measurements were performed with a confocal
setup using an inverted Olympus IX71 microscope (Center Valley,
PA) equipped with a picosecond pulsed diode laser (PicoQuant GmbH,
Berlin,Germany)with emission at 467 nmas excitation source. The laser
power used in the experiments was 3 lW and the pulse frequency of
40 MHz.The laser beamwas focused in the sample volumeusing an apo-
chromatic 60· water immersion objective of numerical aperture 1.2 and
the emitted ﬂuorescence was collected using the same objective and sep-
arated from excitation beam by a dichroic mirror. A 50 lm pinhole was
used to reject oﬀ-focus ﬂuorescence from the excitation volume. To en-
sure photon counting emitted by the donor ﬂuorochrome only, a band-
pass ﬁlter (475–485 nm, Omega Optical, Brattleboro, VT) was placed in
front of the single photon avalanche photodiodes (SPAD; SPCM-AQR,
Perkin–Elmer Inc., Waltham, MA). The ﬂuorescence was measured
using time correlated single photon counting (TCSPC) in time tagged
time resolved (TTTR) mode (Time Harp200, PicoQuant). To obtain
ﬂuorescence lifetimes, TCSPC decay curves were ﬁtted by double expo-
nential using the SymphoTime software (PicoQuant). FRET eﬃciencies
(E) were calculated using the equation:
E ¼ 1 ðsDA=sDÞ
with sDA and sD the donor excited state lifetime in the presence and
absence of acceptor, respectively.2.7. Cyclic AMP accumulation assays
Cyclic AMP measurements were performed in HEK293 cells as de-
scribed [14] in order to verify M4R function. Forskolin (30 lM) was
used to stimulate adenylyl cyclase. Carbachol (1 lM) and atropine
(10 lM) were used as M4R agonist and antagonist, respectively. Stim-
ulations were performed at 37 C for 5 min in the presence of the phos-
phodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX, 500 lM).mplementation (yellow) in cells transfected with A2AR-VN and A2AR-
ker mCherry-Mem, were monitored by ﬂuorescence microscopy. (B)
VC, or M4R-VC was quantiﬁed by ﬂuorometry. BiFC signals were
hree independent experiments assayed in triplicate. Diﬀerent symbols
onferronis post hoc test). (C) A2AR-VN and A2AR-VC fusions were
ell as signals from co-transfected mCherry-Mem were detected by
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3.1. A2AR dimers detected by BiFC in CAD neuronal cells
We chose to study A2AR oligomerization in the CAD neuro-
nal cell line that endogenously express adenosine and dopa-
mine receptors [18–20]. A2AR fusions to N- and C-terminal
portions of the cyan ﬂuorescent protein Cerulean (A2AR-CN
and A2AR-CC) or the yellow ﬂuorescent protein Venus
(A2AR-VN and A2AR-VC) were transiently expressed in
CAD cells. The C-terminal tagged A2A receptors retained the
ability to bind [3H] ZM 241–385 and to stimulate adenylyl cy-
clase (AC) through coupling to Gas ([14] and data not shown).
C-Terminal BiFC fusions to the muscarinic M4 receptor
(M4R) and to the dopamine D1 receptor (D1R) that were used
in control experiments also retained the ability to regulate AC
([14] and Supplementary Fig. S1). Therefore, the BiFC tags
had no detrimental eﬀect on receptor function.
Co-expression of A2AR-VN and A2AR-VC in CAD or
HEK293 cells resulted in robust bimolecular ﬂuorescence com-
plementation (Fig. 1), indicating A2AR dimerization and con-
sistent with previous studies [21,22]. A2AR-VN/A2AR-VC
signals largely overlapped at the cell surface with the mem-
brane marker mCherry-Mem (see below). No ﬂuorescence
was observed in cells expressing only VN or VC fragments
(data not shown). Normalized BiFC signals in cells expressing
A2AR-VN and A2AR-VC (6.57±0.57; n = 49) were markedly
higher than in control transfections with A2AR-VN and
M4R-VC (0.48±0.06; n = 74) (Fig. 1A). Moreover, whole cell
ﬂuorescence intensity in A2AR-VN/A2AR-VC-transfected cellsFig. 2. Sub-cellular localization of A2AR/A2AR oligomers. (A) CAD cells w
YFP-Golgi, YFP-ER, mCherry-Mem, or YFP-Endo (in red). Overlapping
Cerulean, A2AR-VN, and A2AR-VC were analyzed by ﬂuorescence microsco
cyan and yellow, respectively. Scale bars: 5 lm.was much stronger than in control transfections with A2AR-
VN/D1R-VC or A2AR-VN/M4R-VC (Fig. 1B), indicating spec-
iﬁcity of the measured A2AR/A2AR interaction.
3.2. Sub-cellular localization of A2AR dimers
To further address the localization of A2AR/A2AR dimers
in CAD cells, A2AR-CN/A2AR-CC was co-transfected with
four diﬀerent ﬂuorescent markers (Fig. 2A). Consistent with
recent studies indicating that GPCR dimerization occurs at
the ER [23–25], A2AR-CN/A2AR-CC ﬂuorescence showed a
moderate level of overlap with the ER marker (YFP-ER;
YFP fused to the ER targeting sequence of calreticulin and
the KEDL ER retrieval sequence) and with the transmedial
Golgi marker (YFP-Golgi; YFP fusion to residues 1–81 of
the 1,4-galactosyltransferase). Intracellular A2AR/A2AR sig-
nals also co-localized with structures labeled with the endo-
somal marker RhoB [26] fused to YFP (YFP-Endo),
suggesting traﬃcking of A2AR homodimers through early
endosomes [27]. In the vast majority of the cells, distinct
and robust cell surface signals were observed that co-local-
ized with the membrane marker (mCherry-Mem, an N-termi-
nal fragment of Gap43 fused to mCherry), suggesting
eﬃcient plasma membrane targeting of A2AR/A2AR [12,22].
Because over-expression of ﬂuorescently tagged markers
may have inﬂuenced the expression and targeting of A2AR/
A2AR, A2AR-VN and A2AR-VC were transfected in CAD
cells in the absence of markers. Similar A2AR/A2AR ﬂuores-
cence patterns were observed in the presence and absence of
the cellular markers (compare Fig. 2A and Supplementaryere co-transfected with A2AR-CN and A2AR-CC (in green), as well as
signals in merged images appear yellow. (B) Cells expressing A2AR-
py. Cerulean signals and Venus complementation signals are shown in
3988 P.-A. Vidi et al. / FEBS Letters 582 (2008) 3985–3990Fig. 2). Virtually all cells displayed A2AR/A2AR signals at
the cell surface. Most cells displayed varying extents of
A2AR/A2AR in vesicular structures and in diﬀuse intracellu-
lar domains (ER), and some cells displayed clear golgi pat-
terns. Cell-to-cell variations in the relative portion of ER,
golgi, and vesicular labeling may reﬂect physiological diﬀer-
ences or diﬀerent states of cellular diﬀerentiation. In CAD
cells expressing A2AR-VN/A2AR-VC and A2AR-Cerulean,
Venus and Cerulean signals overlapped (Fig. 2B), further
indicating proper targeting of BiFC-tagged receptors. Fluo-
rescence complementation signals were also detected in
HEK293 cells transfected with A2AR-VN and A2AR-VC
(Fig. 1C). However, the ﬂuorescence patterns indicated re-
duced surface expression and increased ER retention of
A2AR-VN/A2AR-VC in HEK293 cells compared to CAD
cells. These observations suggest that neuronal factors in
CAD cells may play a role in A2AR expression and
targeting.Fig. 3. Detection of A2AR higher-order oligomers by combining BiFC and F
and BiFC-FRET (bottom) assays. Cerulean (C) or Venus (V) serve as do
fragments reconstitute Venus and serve as acceptor. (B) Intensity FRET meas
Venus (red), A2AR-VN + A2AR-VC (blue), or M4R-Venus as control (gray).
solely with Cerulean or Venus fusions. #, P < 0.05 compared to A2AR + A
unpaired t-tests, n = 3–4). The C5V and CTV concatemers of Cerulean and V
measurements. CAD cells expressing A2AR-Cerulean and A2AR-Venus, A2
ﬂuorescence lifetime measurements. Data are means ± S.E.M. from at least ﬁ
three) is shown. FRET eﬃciency values (means ± S.E.M.) are indicated. *
Dunnetts post hoc test). (D) Lifetime images from representative cells analyz
bars: 5 lm.3.3. Higher-order A2AR oligomers detected by combined BiFC-
FRET
Previous experiments have suggested the existence of higher-
order GPCR oligomers containing A2AR receptors [14]. Thus,
we used a novel experimental approach combining BiFC and
FRET (Fig. 3A) to explore this possibility further. FRET is
an established technique for studying protein–protein interac-
tions in living cells that has been extensively applied to study
GPCR dimerization (see [28] for review). FRET relies on the
transfer of energy from a donor to an acceptor ﬂuorophore
occurring when both ﬂuorophores reside in close vicinity
(<10 nm). Several methods that measure changes in donor
ﬂuorescence intensity or lifetime have been developed to quan-
tify FRET [29,30]. We ﬁrst performed intensity FRET mea-
surements with suspensions of cell expressing Cerulean
(FRET donor) and Venus (FRET acceptor) fusion proteins.
As shown in Fig. 3B, our system allowed us to discriminate be-
tween FRET signals from Cerulean–Venus concatemers withRET techniques. (A) Schematic representation of classical FRET (top)
nor and acceptor, respectively. In BiFC-FRET experiments, VN/VC
urements. CAD cells were transfected with A2AR-Cerulean and A2AR-
Mix represents energy transfer in mixed populations of cells transfected
2AR or A2AR + A2AR/A2AR; **, P < 0.01; ***, P < 0.001 (two-tailed
enus were used to validate the FRET measurements. (C) FLIM-FRET
AR-VN + A2AR-VC, or M4R-VN +M4R-VC were used for Cerulean
ve diﬀerent image ﬁelds (15 cells). A representative experiment (out of
, P < 0.05; ***, P < 0.001 compared to A2AR-C (ANOVA followed
ed in C are shown together with the corresponding intensity scale. Scale
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which Cerulean is connected to Venus by a 5 amino acid linker
produced stronger FRET than the CTV construct, in which
the ﬂuorescent proteins are separated by 229 amino acids.
FRET was detected in cells transfected with A2AR-Cerulean
and A2AR-Venus, consistent with dimerization of A2AR recep-
tors (Fig. 3B). Cells expressing A2AR-Cerulean, A2AR-VN,
and A2AR-VC also displayed FRET signals, suggesting the
existence of A2AR oligomers with more than two protomers.
Very low signals were obtained from mixed cell populations
(expressing either Cerulean or Venus fusions). Moreover, sig-
niﬁcantly lower energy transfer was observed in control exper-
iments where the M4R receptor replaced A2AR as acceptor. To
further conﬁrm the intensity FRET data, ﬂuorescence lifetime
measurements were undertaken. In contrast to intensity-based
FRET measurements which are complicated by the necessity
of correcting for ﬂuorescence cross-talk and bleed-through
resulting from spectral overlap between donor and acceptors,
FLIM-FRET relies on donor lifetime measurements and hence
represents an independent method to quantify FRET. De-
creased Cerulean lifetime indicative of FRET was measured
in cells expressing A2AR-Cerulean and A2AR-Venus or
A2AR-Cerulean, A2AR-VN, and A2AR-VC (Fig. 3C and D)
but not in transfections with A2AR-Cerulean, M4R-VN, and
M4R-VC. Venus ﬂuorescence was detected in cells expressing
M4R-VN/M4R-VC and A2AR-Cerulean (Supplementary
Fig. 1B), indicating that the absence of energy transfer in
A2AR-Cerulean/M4R-VN/M4R-VC transfections was not
caused by the absence of an acceptor. When regions of interest
only comprising cell surface were analyzed, very similar Ceru-
lean lifetimes were measured (Supplementary Fig. 3). To-
gether, these results highlight the propensity of A2AR to
homo-dimerize and further indicate that A2A receptors assem-
ble into higher-order oligomers at the plasma membrane.4. Discussion
Although GPCRs have been proposed to associate as high-
er-order oligomers (‘‘mosaics’’) at the plasma membrane [3],
and a growing number of GPCR–GPCR interactions are being
reported [5], most classical techniques are restricted to the
detection of two interacting proteins, leaving open the possibil-
ity that (at least some) GPCRs form ‘‘alternative dimers’’.
Only recently has the development of new, non-invasive, ap-
proaches allowed scientists to probe for higher-order GPCR
complexes. By implementing a three-chromophore FRET (3-
FRET) protocol [33], Lopez-Gimenez and colleagues [34]
showed that recombinant a1b-adrenoreceptors exist as high-
er-order oligomers in HEK293 cells. Moreover, with the
development of a new technique in which sequential biolumi-
nescence resonance energy transfer (BRET) and FRET
(SRET) detection serves as a readout for trivalent protein com-
plexes, Carriba et al. [35] have demonstrated hetero-oligomer-
ization of A2A, D2 and cannabinoid CB1 receptors. Finally, a
combination of BRET and BiFC was used to identify ternary
complexes between calcitonin receptor-like receptors and the
receptor activity-modifying protein 1 [36].
A related technique combining BiFC and FRET for the
detection of trivalent protein complex has been recently devel-
oped [37]. While BRET assays (as well as combined assaysusing BRET) are used to assess the aﬃnity and speciﬁcity of
protein–protein interactions [38], BiFC-FRET, when measured
using the standard 3-cube method [39] or with FLIM, allows
not only the detection of ternary complex formation, but also
the identiﬁcation of the sub-cellular localization of the interac-
tion. Moreover, in contrast to the 3-FRET technique which
also has spatial resolution, BiFC-FRET does not require
sophisticated ﬁlter combinations and data processing. Because
of the irreversible nature of BiFC [15], it should, however, be
emphasized that the technique is likely to stabilize the forma-
tion and to facilitate the detection of oligomeric partners.
In this report, we used BiFC-FRET to probe for higher-or-
der GPCR oligomers in the neuronal CAD cell model. The
data demonstrate the assembly of A2AR in higher-order oligo-
mers. While preparing this manuscript, a report by Gandia
et al. [40] was published in which trivalent A2AR complexes
were detected with the BiFC-BRET assay: co-expression of
A2AR fusions to N- and C-terminal fragments from the yellow
ﬂuorescent protein and to Renilla luciferase resulted in satura-
ble BRET signals indicative of trimeric A2AR complexes. Our
data conﬁrm and expand these ﬁndings by demonstrating the
existence of higher-order A2AR oligomers at the plasma mem-
brane, the recognized site of action of A2ARs. In addition to
forming homomers, A2A receptors are known to associate in
heteromeric complexes, notably with adenosine A1 [22,41],
dopamine D2 [11–14], cannabinoid CB1 [42], and glutamate
mGlu5 [43] receptors. Future experiments using the BiFC-
FRET technique described here will investigate higher-order
GPCR heteromers. We have recently shown that prolonged
A2AR or D2R stimulation aﬀects the proportion of receptors
engaging in homodimers and heterodimers [14] and of partic-
ular interest will be the analysis of drug eﬀects on higher-order
GPCR assemblies.
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